Evidence map›Paper›PMID 33078410›Full record

ArticleJournal of cellular physiology2021

Transient receptor potential vanilloid 4 channel deletion regulates pathological but not developmental retinal angiogenesis.

Holly C Cappelli, Brianna D Guarino, Anantha K Kanugula, Ravi K Adapala, Vidushani Perera, Matthew A Smith, Sailaja Paruchuri, Charles K Thodeti

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Regulation of Collecting Lymphatic Vessel Contractile Function by TRPV4 Channels.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Holly C CappelliDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Brianna D GuarinoDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Anantha K KanugulaDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Ravi K AdapalaDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Vidushani PereraDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Matthew A SmithDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Sailaja ParuchuriDepartment of Chemistry, University of Akron, Akron, Ohio, USA.
Charles K ThodetiDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.ORCID 0000-0001-8823-2663
Kent State University · USNortheast Ohio Medical University · USAkron Children's Hospital · USUniversity of Akron · US

Funding

Mechanical Control of Coronary Angiogenesis in Myocardial Adaptation to IschemiaR01HL148585 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI THODETI, CHARLES K · 2019 to 2022
$1.8M
Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast Cell Activation and Pulmonary Inflammation during AsthmaR01AI144115 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI PARUCHURI, SAILAJA · 2019 to 2023
$1.8M
Mechanotransduction in myocardial adaptation to ischemiaR01HL119705 · NHLBI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI THODETI, CHARLES K · 2015 to 2018
$1.5M
Integration of Mechanical and Soluble Signaling in Tumor AngiogenesisR15CA202847 · NCI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI THODETI, CHARLES K · 2016 to 2016
$453k
NCI NIH HHS R15 CA202847NHLBI NIH HHS R01 HL119705NHLBI NIH HHS R01 HL148585NIAID NIH HHS R01 AI144115NIH HHS R01AI144115NIH HHS R01HL119705NIH HHS R01HL148585NIH HHS R15CA202847
6 · The paper itself

Abstract

Transient receptor potential vanilloid 4 (TRPV4) channels are mechanosensitive ion channels that regulate systemic endothelial cell (EC) functions such as vasodilation, permeability, and angiogenesis. TRPV4 is expressed in retinal ganglion cells, Müller glia, pigment epithelium, microvascular ECs, and modulates cell volume regulation, calcium homeostasis, and survival. TRPV4-mediated physiological or pathological retinal angiogenesis remains poorly understood. Here, we demonstrate that TRPV4 is expressed, functional, and mechanosensitive in retinal ECs. The genetic deletion of TRPV4 did not affect postnatal developmental angiogenesis but increased pathological neovascularization in response to oxygen-induced retinopathy (OIR). Retinal vessels from TRPV4 knockout mice subjected to OIR exhibited neovascular tufts that projected into the vitreous humor and displayed reduced pericyte coverage compared with wild-type mice. These results suggest that TRPV4 is a regulator of retinal angiogenesis, its deletion augments pathological retinal angiogenesis, and that TRPV4 could be a novel target for the development of therapies against neovascular ocular diseases.

Indexed as

Gene DeletionNeovascularization, PhysiologicAnimalsEndothelial CellsHumansMechanotransduction, CellularMiceMice, Inbred C57BLMicrovesselsOxygenPericytesRetinaRetinal NeovascularizationTRPV Cation ChannelsOxygenTRPV4 protein, humanTrpv4 protein, mouseTRPV Cation ChannelsECM stiffnesshuman retinal endothelial cellsmechanotransductionneovascularizationTRPV4

Identifiers

PMID33078410
PMCPMC7920906
OpenAlexW3092820905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.